FindTrial
Sign In

Can early Pregnancy Levels of C-Peptide, Insulin, and Sugar Control (HbA1C) help Predict the Risk of Diabetes During Pregnancy

To study the role of first trimester value of C peptide, insulin and HbA1C levels in predicton of gestational diabetes mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091970
Enrollment
225
Registered
2025-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O244- Gestational diabetes mellitus

Interventions

Intervention1: Nil: Nil

Sponsors

Chittilappilly Rappai Jincy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All singleton pregnant women older than 18 years, within their first trimester of pregnancy (by the end of the 14th week of their gestational age)

Exclusion criteria

Exclusion criteria: Pregnant women with pre-existing type I or II Diabetes mellitus

Design outcomes

Primary

MeasureTime frame
To perform DIPSI, C peptide, insulin and HbA1C in first trimester and assess and compare its predictive efficacy in detecting gestational diabetes mellitus.Timepoint: within 14 wks and 24 - 28 wks—

Secondary

MeasureTime frame
To know the neonatal outcome (birth weight, blood sugar level at 1 hr ) in relation with first trimester C peptide, insulin and HbA1C value.Timepoint: Preliminary Action 02 months Data Collection 20 months Analysis & Write up 02 months Total Time 24 months—

Countries

India

Contacts

Public ContactDr Pallavi Verma

INHS Asvini, Institute of Naval Medicine

chawla_sushil@rediffmail.com70304 99665

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026